OSELTAMIVIR PHOSPHATE - oseltamivir acid suspension 
Cadila Healthcare Limited

----------

Oseltamivir Phosphate for Oral Suspension

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 70771-1598-6

Oseltamivir Phosphate for Oral Suspension

6 mg/mL *

60 mL (usable volume after constitution)

mfg label
OSELTAMIVIR PHOSPHATE 
oseltamivir acid suspension
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1598
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OSELTAMIVIR PHOSPHATE (UNII: 4A3O49NGEZ) (OSELTAMIVIR ACID - UNII:K6106LV5Q8) OSELTAMIVIR ACID6 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
MONOSODIUM CITRATE (UNII: 68538UP9SE)  
SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SORBITOL (UNII: 506T60A25R)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
WATER (UNII: 059QF0KO0R)  
XANTHAN GUM (UNII: TTV12P4NEE)  
Product Characteristics
ColorWHITE (White) Score    
ShapeSize
FlavorTUTTI FRUTTIImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70771-1598-660 mL in 1 BOTTLE; Type 0: Not a Combination Product08/05/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20911308/05/2021
Labeler - Cadila Healthcare Limited (918596198)
Establishment
NameAddressID/FEIBusiness Operations
CADILA HEALTHCARE LIMITED677605858ANALYSIS(70771-1598) , MANUFACTURE(70771-1598)

Revised: 8/2021
Document Id: 396be9cc-cc64-4337-adf3-52339dd7f2ba
Set id: 7c0923ad-80b0-4134-b44a-754ea599f356
Version: 1
Effective Time: 20210805
 
Cadila Healthcare Limited